Related Experiment Video
Updated: Jun 14, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
Published on: August 4, 2022
Tumor necrosis factor-alpha converting enzyme: Implications for ocular inflammatory diseases.
1Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, USA. kvramana@utmb.edu
Tumor necrosis factor-alpha (TNF-alpha) converting enzyme (TACE) inhibitors show promise for treating inflammatory eye diseases like uveitis. By blocking TNF-alpha processing, these inhibitors may prevent ocular tissue damage and vision loss.
Area of Science:
- Ocular immunology
- Inflammatory diseases
- Enzyme function
Background:
- Tumor necrosis factor-alpha (TNF-alpha) converting enzyme (TACE) processes TNF-alpha, a key cytokine in inflammation.
- While TACE inhibitors are studied for systemic inflammatory diseases, their role in ocular pathologies is less understood.
- Ocular TACE activity may contribute to tissue damage and vision loss through cytokine and growth factor shedding.
Purpose of the Study:
- To explore the potential of TACE inhibitors as a therapeutic strategy for ocular inflammatory diseases.
- To highlight the implications of TACE activity regulation in ocular immunology.
Main Methods:
- Review of existing literature on TACE, TNF-alpha, and ocular inflammatory conditions.
- Analysis of the role of TACE-mediated cytokine shedding in ocular tissue dysfunction.
Main Results:
- TACE plays a role in processing cytokines and growth factors in the eye.
- Dysregulation of TACE activity can lead to cytotoxic signals, tissue damage, and blindness.
- Anti-TNF-alpha therapies are established for ocular inflammation.
Conclusions:
- TACE inhibitors represent a novel therapeutic avenue for ocular inflammatory diseases, particularly uveitis.
- Targeting TACE could offer a new approach to managing inflammatory eye conditions and preventing vision loss.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
The Tumor Microenvironment
Cytotoxic Edema: Pathophysiology
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Glaucoma: Overview
Inflammatory Bowel Disease II: Ulcerative Colitis